The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 2, 2025 | Cloonan Michael | Director | Disposed to issuer(D) | 2K | — | — |
| Jun 2, 2025 | Paulson Richard A. | Director | Disposed to issuer(D) | 1K | — | — |
| Jun 2, 2025 | Leschly Nick | Director | Disposed to issuer(D) | 1K | — | — |
| Jun 2, 2025 | Sterling O. James | Chief Financial Officer | Grant(A) | 3K | — | — |
| Jun 2, 2025 | Sterling O. James | Chief Financial Officer | Disposed to issuer(D) | 5K | — | — |
| Jun 2, 2025 | Sterling O. James | Chief Financial Officer | Disposed to issuer(D) | 3K | — | — |
| Jun 2, 2025 | Klima Thomas J | See Remarks | Grant(A) | 3K | — | — |
| Jun 2, 2025 | Klima Thomas J | See Remarks | Disposed to issuer(D) | 4K | — | — |
| Jun 2, 2025 | Klima Thomas J | See Remarks | Disposed to issuer(D) | 3K | — | — |
| Jun 2, 2025 | Jones-Burton Charlotte | Director | Disposed to issuer(D) | 1K | — | — |
| Jun 2, 2025 | Leiderman Elisabeth | Director | Disposed to issuer(D) | 1K | — | — |
| Jun 2, 2025 | Obenshain Andrew | President and CEO, Director | Disposed to issuer(D) | 9K | — | — |
| Jun 2, 2025 | Obenshain Andrew | President and CEO, Director | Grant(A) | 15K | — | — |
| Jun 2, 2025 | Obenshain Andrew | President and CEO, Director | Disposed to issuer(D) | 15K | — | — |
| Jun 2, 2025 | Tita-Reid Najoh | Director | Disposed to issuer(D) | 1K | — | — |
| Jun 2, 2025 | Colvin Richard A | Chief Medical Officer | Disposed to issuer(D) | 4K | — | — |
| Jun 2, 2025 | Colvin Richard A | Chief Medical Officer | Grant(A) | 3K | — | — |
| Jun 2, 2025 | Colvin Richard A | Chief Medical Officer | Disposed to issuer(D) | 3K | — | — |
| Jun 2, 2025 | Vachon Mark | Director | Disposed to issuer(D) | 1K | — | — |
| Jun 2, 2025 | Agwunobi John O | Director | Disposed to issuer(D) | 1K | — | — |
| Jun 2, 2025 | Vittiglio Joseph | Chief Business & Legal Officer | Grant(A) | 3K | — | — |
| Jun 2, 2025 | Vittiglio Joseph | Chief Business & Legal Officer | Disposed to issuer(D) | 3K | — | — |
| Jun 2, 2025 | Vittiglio Joseph | Chief Business & Legal Officer | Disposed to issuer(D) | 3K | — | — |
| May 30, 2025 | Paulson Richard A. | Director | Tender(U) | 155 | — | — |
| May 30, 2025 | Leschly Nick | Director | Tender(U) | 6K | — | — |
| May 30, 2025 | Leschly Nick | Director | Tender(U) | 14K | — | — |
| May 30, 2025 | Leschly Nick | Director | Tender(U) | 2K | — | — |
| May 30, 2025 | Klima Thomas J | See Remarks | Tender(U) | 3K | — | — |
| May 30, 2025 | Jones-Burton Charlotte | Director | Tender(U) | 928 | — | — |
| May 30, 2025 | Leiderman Elisabeth | Director | Tender(U) | 1K | — | — |
| May 30, 2025 | Obenshain Andrew | President and CEO, Director | Tender(U) | 9K | — | — |
| May 30, 2025 | Tita-Reid Najoh | Director | Tender(U) | 1K | — | — |
| May 30, 2025 | Colvin Richard A | Chief Medical Officer | Tender(U) | 4K | — | — |
| May 30, 2025 | Vachon Mark | Director | Tender(U) | 1K | — | — |
| May 30, 2025 | Agwunobi John O | Director | Tender(U) | 1K | — | — |
| May 30, 2025 | Vittiglio Joseph | Chief Business & Legal Officer | Tender(U) | 1K | — | — |
| Mar 3, 2025 | Obenshain Andrew | President and CEO, Director | Sell(S) | 921 | $3.92 | $4K |
| Mar 3, 2025 | Klima Thomas J | See Remarks | Sell(S) | 500 | $3.92 | $2K |
| Mar 3, 2025 | Colvin Richard A | Chief Medical Officer | Sell(S) | 584 | $3.92 | $2K |
| Feb 10, 2025 | Obenshain Andrew | President and CEO, Director | Grant(A) | 763 | — | $0 |
| Feb 3, 2025 | Obenshain Andrew | President and CEO, Director | Sell(S) | 86 | $7.39 | $636 |
| Feb 3, 2025 | Vittiglio Joseph | Chief Business & Legal Officer | Sell(S) | 238 | $7.39 | $2K |
| Feb 3, 2025 | Colvin Richard A | Chief Medical Officer | Sell(S) | 64 | $7.39 | $473 |
| Feb 3, 2025 | Klima Thomas J | See Remarks | Sell(S) | 122 | $7.39 | $902 |
| Jan 6, 2025 | Obenshain Andrew | President and CEO, Director | Sell(S) | 140 | $9.24 | $1K |
| Jan 6, 2025 | Colvin Richard A | Chief Medical Officer | Sell(S) | 19 | $9.24 | $176 |
| Dec 10, 2024 | Colvin Richard A | Chief Medical Officer | Sell(S) | 3K | $0.42 | $1K |
| Dec 10, 2024 | Obenshain Andrew | President and CEO, Director | Sell(S) | 971 | $0.42 | $408 |
| Nov 6, 2024 | Vachon Mark | Director | Grant(A) | 25K | — | $0 |
| Nov 6, 2024 | Vachon Mark | Director | Grant(A) | 50K | — | $0 |
| Nov 6, 2024 | Leiderman Elisabeth | Director | Grant(A) | 25K | — | $0 |
| Nov 6, 2024 | Leiderman Elisabeth | Director | Grant(A) | 50K | — | $0 |
| Nov 6, 2024 | Agwunobi John O | Director | Grant(A) | 25K | — | $0 |
| Nov 6, 2024 | Agwunobi John O | Director | Grant(A) | 50K | — | $0 |
| Nov 6, 2024 | Jones-Burton Charlotte | Director | Grant(A) | 25K | — | $0 |
| Nov 6, 2024 | Jones-Burton Charlotte | Director | Grant(A) | 50K | — | $0 |
| Nov 6, 2024 | Paulson Richard A. | Director | Grant(A) | 25K | — | $0 |
| Nov 6, 2024 | Paulson Richard A. | Director | Grant(A) | 50K | — | $0 |
| Nov 6, 2024 | Leschly Nick | Director | Grant(A) | 25K | — | $0 |
| Nov 6, 2024 | Leschly Nick | Director | Grant(A) | 50K | — | $0 |
| Nov 6, 2024 | Tita-Reid Najoh | Director | Grant(A) | 25K | — | $0 |
| Nov 6, 2024 | Tita-Reid Najoh | Director | Grant(A) | 50K | — | $0 |
| Sep 30, 2024 | Obenshain Andrew | President and CEO, Director | Sell(S) | 35K | $0.53 | $18K |
| Sep 30, 2024 | Obenshain Andrew | President and CEO, Director | Grant(A) | 130K | — | $0 |
| Sep 30, 2024 | Klima Thomas J | See Remarks | Grant(A) | 50K | — | $0 |
| Sep 30, 2024 | Klima Thomas J | See Remarks | Sell(S) | 1K | $0.53 | $533 |
| Sep 30, 2024 | Cloonan Michael | Director | Grant(A) | 37K | — | $0 |
| Sep 30, 2024 | Sterling O. James | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Sep 30, 2024 | Vittiglio Joseph | Chief Business & Legal Officer | Grant(A) | 50K | — | $0 |
| Sep 30, 2024 | Colvin Richard A | Chief Medical Officer | Grant(A) | 50K | — | $0 |
| Jul 1, 2024 | Sterling O. James | Chief Financial Officer | Grant(A) | 300K | — | $0 |
| Jun 20, 2024 | Cloonan Michael | Director | Grant(A) | 75K | — | $0 |
| Jun 3, 2024 | Klima Thomas J | See Remarks | Sell(S) | 4K | $0.97 | $4K |
| Mar 4, 2024 | Klima Thomas J | See Remarks | Sell(S) | 5K | $1.53 | $7K |
| Mar 4, 2024 | Obenshain Andrew | President and CEO, Director | Sell(S) | 6K | $1.53 | $9K |
| Mar 1, 2024 | Klima Thomas J | See Remarks | Grant(A) | 199K | — | $0 |
| Mar 1, 2024 | Obenshain Andrew | President and CEO, Director | Grant(A) | 650K | — | $0 |
| Mar 1, 2024 | Krawtschuk Christopher | Chief Financial Officer | Grant(A) | 199K | — | $0 |
| Mar 1, 2024 | Vittiglio Joseph | Chief Business & Legal Officer | Grant(A) | 199K | — | $0 |
| Mar 1, 2024 | Colvin Richard A | Chief Medical Officer | Sell(S) | 7K | $1.53 | $10K |
| Mar 1, 2024 | Colvin Richard A | Chief Medical Officer | Grant(A) | 199K | — | $0 |
| Feb 5, 2024 | Obenshain Andrew | President and CEO, Director | Sell(S) | 2K | $0.90 | $2K |
| Feb 5, 2024 | Vittiglio Joseph | Chief Business & Legal Officer | Sell(S) | 5K | $0.90 | $5K |
| Feb 5, 2024 | Klima Thomas J | See Remarks | Sell(S) | 3K | $0.90 | $2K |
| Jan 5, 2024 | Colvin Richard A | Chief Medical Officer | Sell(S) | 597 | $1.42 | $848 |
| Jan 5, 2024 | Obenshain Andrew | President and CEO, Director | Sell(S) | 3K | $1.43 | $5K |
| Dec 6, 2023 | Krawtschuk Christopher | Chief Financial Officer | Sell(S) | 5K | $4.52 | $20K |
| Nov 3, 2023 | Obenshain Andrew | President and CEO, Director | Sell(S) | 807 | $3.17 | $3K |
| Nov 2, 2023 | Colvin Richard A | Chief Medical Officer | Sell(S) | 2K | $2.98 | $7K |
| Sep 5, 2023 | Klima Thomas J | See Remarks | Sell(S) | 922 | $3.79 | $3K |
| Aug 10, 2023 | Obenshain Andrew | President and CEO, Director | Sell(S) | 17K | $3.54 | $60K |
| Jun 16, 2023 | Jones-Burton Charlotte | Director | Grant(A) | 11K | — | $0 |
| Jun 16, 2023 | Jones-Burton Charlotte | Director | Grant(A) | 22K | — | $0 |
| Jun 16, 2023 | Leschly Nick | Director | Grant(A) | 11K | — | $0 |
| Jun 16, 2023 | Leschly Nick | Director | Grant(A) | 22K | — | $0 |
| Jun 16, 2023 | Leiderman Elisabeth | Director | Grant(A) | 11K | — | $0 |
| Jun 16, 2023 | Leiderman Elisabeth | Director | Grant(A) | 22K | — | $0 |
| Jun 16, 2023 | Vachon Mark | Director | Grant(A) | 11K | — | $0 |
| Jun 16, 2023 | Vachon Mark | Director | Grant(A) | 22K | — | $0 |
| Jun 16, 2023 | Agwunobi John O | Director | Grant(A) | 11K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).